2003, Volume 10, Supplement 4: Phosphodiesterase type 5 (PDE5) inhibitors: looking beyond erectile dysfunction
September 2003 Br J Cardiol 2003;10(Suppl 4):S1-S8
Phosphodiesterase type 5 (PDE5) inhibitors: looking beyond erectile dysfunction
Dr Graham Jackson, Dr Bill Alexander, Dr Marc Evans, Professor Roger Hall, Dr Diana Holdright, Dr Michael Kirby, Mr David Ralph, Dr Stuart Hood, Ms Emma Martin
A round-table meeting to discuss the management of erectile dysfunction was held in London in June. Participants heard about the cardiac safety and cardiac potential of PDE5 inhibitors, and agreed a number of points about the clinical benefits and use of these agents. This supplement contains a report of the meeting....
